| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Valcyte (valganciclovir HCI) Tablets, 450 mg, Hoffman-La Roche NDA 21-304/S1 9/12/03 9/25/03 9/25/03 Valcyte (valganciclovir HCI) Tablets, 450 mg, Roche Global Development-Palo NDA 21-304 3/29/01 4/13/01 4/13/01 Valcyte Indications: Treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). |
|
© 2009 Betterchem.com
|